Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1951 1
1952 1
1954 1
1956 1
1963 1
1967 1
1983 2
1984 1
1986 1
1987 1
1988 3
1989 3
1990 1
1991 3
1992 2
1993 2
1994 4
1995 2
1996 1
1997 8
1998 4
1999 3
2001 4
2002 8
2003 5
2004 3
2005 9
2006 9
2007 10
2008 15
2009 25
2010 21
2011 21
2012 14
2013 9
2014 14
2015 17
2016 10
2017 13
2018 13
2019 22
2020 29
2021 33
2022 36
2023 5
Text availability
Article attribute
Article type
Publication date

Search Results

340 results
Results by year
Filters applied: . Clear all
Page 1
Derivation and validation of the predicting bleeding complications in patients undergoing stent implantation and subsequent dual antiplatelet therapy (PRECISE-DAPT) score: a pooled analysis of individual-patient datasets from clinical trials.
Costa F, van Klaveren D, James S, Heg D, Räber L, Feres F, Pilgrim T, Hong MK, Kim HS, Colombo A, Steg PG, Zanchin T, Palmerini T, Wallentin L, Bhatt DL, Stone GW, Windecker S, Steyerberg EW, Valgimigli M; PRECISE-DAPT Study Investigators. Costa F, et al. Among authors: van klaveren d. Lancet. 2017 Mar 11;389(10073):1025-1034. doi: 10.1016/S0140-6736(17)30397-5. Lancet. 2017. PMID: 28290994 Review.
Prevention of incisional hernia with prophylactic onlay and sublay mesh reinforcement versus primary suture only in midline laparotomies (PRIMA): 2-year follow-up of a multicentre, double-blind, randomised controlled trial.
Jairam AP, Timmermans L, Eker HH, Pierik REGJM, van Klaveren D, Steyerberg EW, Timman R, van der Ham AC, Dawson I, Charbon JA, Schuhmacher C, Mihaljevic A, Izbicki JR, Fikatas P, Knebel P, Fortelny RH, Kleinrensink GJ, Lange JF, Jeekel HJ; PRIMA Trialist Group. Jairam AP, et al. Among authors: van klaveren d. Lancet. 2017 Aug 5;390(10094):567-576. doi: 10.1016/S0140-6736(17)31332-6. Epub 2017 Jun 20. Lancet. 2017. PMID: 28641875 Clinical Trial.
Redevelopment and validation of the SYNTAX score II to individualise decision making between percutaneous and surgical revascularisation in patients with complex coronary artery disease: secondary analysis of the multicentre randomised controlled SYNTAXES trial with external cohort validation.
Takahashi K, Serruys PW, Fuster V, Farkouh ME, Spertus JA, Cohen DJ, Park SJ, Park DW, Ahn JM, Kappetein AP, Head SJ, Thuijs DJ, Onuma Y, Kent DM, Steyerberg EW, van Klaveren D; SYNTAXES, FREEDOM, BEST, and PRECOMBAT trial investigators. Takahashi K, et al. Among authors: van klaveren d. Lancet. 2020 Oct 31;396(10260):1399-1412. doi: 10.1016/S0140-6736(20)32114-0. Epub 2020 Oct 8. Lancet. 2020. PMID: 33038944 Clinical Trial.
Dual Antiplatelet Therapy Duration Based on Ischemic and Bleeding Risks After Coronary Stenting.
Costa F, Van Klaveren D, Feres F, James S, Räber L, Pilgrim T, Hong MK, Kim HS, Colombo A, Steg PG, Bhatt DL, Stone GW, Windecker S, Steyerberg EW, Valgimigli M; PRECISE-DAPT Study Investigators. Costa F, et al. Among authors: van klaveren d. J Am Coll Cardiol. 2019 Feb 26;73(7):741-754. doi: 10.1016/j.jacc.2018.11.048. J Am Coll Cardiol. 2019. PMID: 30784667 Free article.
Lung cancer screening.
van Klaveren RJ. van Klaveren RJ. Eur J Cancer. 2011 Sep;47 Suppl 3:S147-55. doi: 10.1016/S0959-8049(11)70158-7. Eur J Cancer. 2011. PMID: 21943968 Review. No abstract available.
Statistical methods for composite endpoints.
Hara H, van Klaveren D, Kogame N, Chichareon P, Modolo R, Tomaniak M, Ono M, Kawashima H, Takahashi K, Capodanno D, Onuma Y, Serruys PW. Hara H, et al. Among authors: van klaveren d. EuroIntervention. 2021 Apr 2;16(18):e1484-e1495. doi: 10.4244/EIJ-D-19-00953. EuroIntervention. 2021. PMID: 32338610 Free PMC article.
Selective Monovalent Galectin-8 Ligands Based on 3-Lactoylgalactoside.
Girardi B, Manna M, Van Klaveren S, Tomašič T, Jakopin Ž, Leffler H, Nilsson UJ, Ricklin D, Mravljak J, Schwardt O, Anderluh M. Girardi B, et al. Among authors: van klaveren s. ChemMedChem. 2022 Feb 4;17(3):e202100514. doi: 10.1002/cmdc.202100514. Epub 2021 Oct 6. ChemMedChem. 2022. PMID: 34613662
Predictive approaches to heterogeneous treatment effects: a scoping review.
Rekkas A, Paulus JK, Raman G, Wong JB, Steyerberg EW, Rijnbeek PR, Kent DM, van Klaveren D. Rekkas A, et al. Among authors: van klaveren d. BMC Med Res Methodol. 2020 Oct 23;20(1):264. doi: 10.1186/s12874-020-01145-1. BMC Med Res Methodol. 2020. PMID: 33096986 Free PMC article. Review.
340 results